Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guerrini

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Annals of Neurology|January 1, 1997
Bilateral parasagittal parietooccipital polymicrogyria and epilepsyR Guerrini, F Dubeau, O Dulac, et al.
Journal of Medicinal Chemistry|November 2, 2001
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptorR Guerrini, G Caló, R Bigoni, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2004
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and miceE C Gavioli, C W Vaughan, G Marzola, et al.
Gene|December 17, 2011
Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohortS Funghini, J Thusberg, M Spada, et al.
British Journal of Pharmacology|March 11, 2018
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505N Dietis, H Niwa, R Tose, et al.
Journal of Medicinal Chemistry|August 24, 2000
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptorR Guerrini, G Caló, R Bigoni, et al.
Biochimica Et Biophysica Acta|November 28, 2009
Functional studies of new GLA gene mutations leading to conformational Fabry diseaseC Filoni, A Caciotti, L Carraresi, et al.
Neurology|August 1, 2007
Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicusR Guerrini, F Moro, M Kato, et al.
Annals of Neurology|July 1, 1996
Cortical myoclonus in Angelman syndromeR Guerrini, T M De Lorey, P Bonanni, et al.
Epilepsy Research|May 8, 1999
Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsiesG Gobbi, A Pini, G Bertani, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Annals of Neurology|January 1, 1997
Bilateral parasagittal parietooccipital polymicrogyria and epilepsyR Guerrini, F Dubeau, O Dulac, et al.
Journal of Medicinal Chemistry|November 2, 2001
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptorR Guerrini, G Caló, R Bigoni, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2004
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and miceE C Gavioli, C W Vaughan, G Marzola, et al.
Gene|December 17, 2011
Carbamoyl phosphate synthetase 1 deficiency in Italy: clinical and genetic findings in a heterogeneous cohortS Funghini, J Thusberg, M Spada, et al.
British Journal of Pharmacology|March 11, 2018
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505N Dietis, H Niwa, R Tose, et al.
Journal of Medicinal Chemistry|August 24, 2000
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptorR Guerrini, G Caló, R Bigoni, et al.
Biochimica Et Biophysica Acta|November 28, 2009
Functional studies of new GLA gene mutations leading to conformational Fabry diseaseC Filoni, A Caciotti, L Carraresi, et al.
Neurology|August 1, 2007
Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicusR Guerrini, F Moro, M Kato, et al.
Annals of Neurology|July 1, 1996
Cortical myoclonus in Angelman syndromeR Guerrini, T M De Lorey, P Bonanni, et al.
Epilepsy Research|May 8, 1999
Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsiesG Gobbi, A Pini, G Bertani, et al.
Pageof 28